The new report by Expert Market Research titled, ‘Global Immunofluorescence Assay Market Size, Report and Forecast 2023-2028’, gives an in-depth analysis of the Global Immunofluorescence Assay market, assessing the market based on its segments like application, end user, and major regions like North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2018-2028)
• Historical Market Size (2022): USD 2.7 billion
• Forecast CAGR (2023-2028): 5.40 %
• Forecast Market Size (2028): USD 3.7 billion
The market for Immunofluorescence Assay has seen substantial growth due to Intestinal cancer, HIV AIDS, Alzheimer’s disease, diverticulitis, Crohn’s disease, ulcerative colitis, and inflammatory bowel disease, among other chronic disorders. The increasing use of immunofluorescence tests in diagnostic and research studies, as well as the increased availability of sophisticated kits and reagents, are aiding the market expansion.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/immunofluorescence-assay-market/requestsample
The immunofluorescence test is a staining or visualisation approach for detecting antibodies based on their capacity to react specifically with viral antigens produced in infected cells. The procedure involves incubating bound antibodies with fluorescently labelled anti-human antibodies and staining just specified cells. Proteins, glycans, and tiny biological and non-biological substances can all be studied using an immunofluorescence assay. It’s a common tool in biological and medical research.
Based on the major products of immunofluorescence assay, the market is divided into:
• Reagents and Kits
• Consumables and Accessories
Based on the types, the market is divided into:
• Indirect Immunofluorescence
• Direct Immunofluorescence
Based on the application, the market is segmented into:
• Infectious Diseases
• Autoimmune Disease
The regional markets include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/immunofluorescence-assay-market
Because of the rising prevalence of chronic and infectious disorders, North America holds a substantial proportion of the immunofluorescence assays market. The market is being boosted by increased spending on research and development (R&D), the implementation of numerous favourable government programmes, and the growing presence of significant important players in the region.
The need for immunofluorescence assays is increasing as laboratories become more automated, technology improves, and reimbursement scenarios become more favourable, boosting the market’s growth. The expanding demand for immunofluorescence assays is likely to be bolstered by rising research and development (R&D) activities for technical improvements, as well as increased government investments in healthcare. In the foreseeable years, the market is expected to develop due to the rising need for reliable healthcare facilities, increased attention on antibody waste, medicines, and various preclinical and clinical research.
Key Market Players
The major players in the market are Thermo Fisher Scientific Inc., Cell Signaling Technology Inc., Bio-Rad Laboratories, Inc., Sino Biological Inc., PerkinElmer Inc., and others.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Shira Ellis, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA